Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2003 Dec 1;21(23):4395-401.
doi: 10.1200/JCO.2003.04.089.

Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group

Dorie A Glover  1 , Julianne Byrne, James L Mills, Leslie L Robison, H Stacy Nicholson, Anna Meadows, Lonnie K Zeltzer; Children's Cancer Group
Affiliations
Comparative Study

Impact of CNS treatment on mood in adult survivors of childhood leukemia: a report from the Children's Cancer Group

Dorie A Glover et al. J Clin Oncol. .

Abstract

Purpose: This study assessed the relationship between CNS treatment and psychologic mood using the Profile of Moods State (POMS), a standardized measure of affect, among a large sample of young adult survivors of childhood acute lymphoblastic leukemia (ALL; N = 555).

Patients and methods: Survivors of childhood ALL (ages 18 to 33 years at study entry) participated in a structured telephone interview eliciting demographic, health, and behavioral data and the POMS. Treatment data included total dose of CNS irradiation (CRT) and intrathecal methotrexate (MTX) obtained from medical records.

Results: Mood disturbance was reported by 24% of survivors. High-dose CRT and MTX predicted disturbance rates modestly and primarily in combination with education variables. Interactions between educational achievement, a history of attendance in special education classes, and sex were better predictors than treatment type or dose. Nonwhite males, those younger than 12.5 years of age at diagnosis, and those with negative perceptions of current health and cancer's impact on employment were also at greater risk for mood disturbance (P <.01 to.001).

Conclusion: Although most survivors are doing well psychologically, a subset of long-term survivors show potentially serious mood disturbance. Mood disturbance seems to be a function of interactions between preexisting individual difference variables (eg, sex, race/ethnicity), treatment factors, and posttreatment educational experiences. Prevention strategies aimed at childhood cancer survivors at greatest risk for mood disturbance may be improved by focus on posttreatment psychosocial and educational supports.

PubMed Disclaimer

Conflict of interest statement

AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

The authors indicated no potential conflicts of interest.

Figures

Fig 1
Fig 1
Risk of mood disturbance as a function of treatment and highest education achieved. MTX, methotrexate; CRT, cranial radiation treatment; hs, high school, grad, graduate.
Fig 2
Fig 2
Risk of mood disturbance as a function of special education history and highest education achieved. HS, high school; spec ed, special education.
See this image and copyright information in PMC

References

    1. Brown RT, Madan-Swain A, Walco GA, et al. Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis. J Pediatr Psychol. 1998;23:333–340. - PubMed
    1. Maidan-Swain A, Brown RT. Cognitive and psychosocial sequelae for children with acute lymphocytic leukemia and their families. Clin Psychol Rev. 1991;11:267–294.
    1. Koocher GP, O’Malley JE, Gogan JL, et al. Psychological adjustment among pediatric cancer survivors. J Child Psychol Psychiatry. 1980;21:163–173. - PubMed
    1. Koocher GP, O’Malley JE: The Damocles Syndrome. New York, NY, McGraw-Hill, 1981
    1. Mackie E, Hill J, Kondryn H, et al. Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms’ tumour: A controlled study. Lancet. 2000;355:1310–1314. - PubMed

Publication types

Substances